Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

16 Feb 2012 07:00

RNS Number : 5060X
Halma PLC
16 February 2012
 



Halma p.l.c.

 

Interim Management Statement

 

16 February 2012

 

 

Halma, the leading safety, health and environmental technology group today makes an Interim Management Statement prior to its financial year end on 31 March 2012, covering the period from 2 October 2011 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles and acquisition costs) for the full year to be in line with market expectations [see note 2].

 

The regional and sector trading patterns reported for the first six months of the financial year have been maintained with slower growth in the UK but higher rates of growth in the USA. Good rates of growth have continued elsewhere including Mainland Europe and emerging markets.

 

Our Industrial Safety businesses continue to deliver very strong results and are all benefitting from increasing revenue from customers in the natural resources and process industries worldwide.

 

Our Health and Analysis sector is achieving the highest rate of revenue growth of the Group, boosted by acquisitions made last year. Water and Health Optics are performing well whilst Photonics and Fluid Technology are trading in line with the first six months.

 

In Infrastructure Sensors, Fire Detection and Automatic Door Sensors are making solid progress. Security Sensors and Elevator Safety are reporting flat revenues in tough market conditions.

 

The two businesses we acquired in the first half, Kirk Key Interlock Company, LLC (Industrial Safety) and Avo Photonics, Inc (Health & Analysis) are trading well and in line with our expectations.

 

We have maintained strong returns and good cash generation. This, together with the £260m 5-year revolving credit facility put in place in October 2011, provides us with financial capacity for further acquisitions. We continue to search for opportunities in all three sectors.

 

There have been no material events or transactions impacting the Group's financial position which remains strong.

 

The results for the financial year ending 31 March 2012 are expected to be released on 14 June 2012.

 

 

For further information, please contact:

 

Halma p.l.c.

Andrew Williams, Group Chief Executive

Kevin Thompson, Group Finance Director

Tel: +44 (0)1494 721111

 

MHP

Rachel Hirst/Andrew Jaques

 

Tel: +44 (0)20 3128 8100

 

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

The Board believes current market forecasts to be in the range of £118.8m to £122.5m with a consensus of £120.6m (2010/11 profit before amortisation of acquired intangibles and acquisition costs: £104.6m).

 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMGMZVKMGZZM
Date   Source Headline
21st Nov 20177:00 amRNSHalf-year Report
1st Nov 20177:00 amRNSAcquisition
4th Oct 20175:54 pmRNSDirector/PDMR Shareholding
28th Sep 20179:57 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSTrading Statement
11th Sep 201712:19 pmRNSDirector Declaration
7th Sep 20179:27 amRNSDirector Declaration
1st Sep 20175:08 pmRNSTotal Voting Rights
16th Aug 20174:02 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSAcquisition
1st Aug 201710:39 amRNSTotal Voting Rights
31st Jul 201712:00 pmRNSNotice of Board Change
20th Jul 20173:57 pmRNSResult of AGM
19th Jul 20172:21 pmRNSDirector Declaration
4th Jul 20173:39 pmRNSDirector/PDMR Shareholding
3rd Jul 201711:29 amRNSTotal Voting Rights
21st Jun 20175:22 pmRNSAnnual Financial Report
13th Jun 20177:00 amRNSFinal Results
1st Jun 20173:02 pmRNSTotal Voting Rights
30th May 201711:00 amRNSNotice of Results
2nd May 20173:39 pmRNSTotal Voting Rights
6th Apr 20179:00 amRNSNotice of Board change
3rd Apr 201711:12 amRNSTotal Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Audit Tender
1st Mar 201712:41 pmRNSTotal Voting Rights
13th Feb 20174:06 pmRNSHolding(s) in Company
1st Feb 201712:07 pmRNSTotal Voting Rights
9th Jan 20179:00 amRNSAcquisition of FluxData
3rd Jan 20174:02 pmRNSTotal Voting Rights
1st Dec 201611:37 amRNSTotal Voting Rights
28th Nov 20163:05 pmRNSDirector/PDMR Shareholding
24th Nov 20164:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:35 pmRNSDoc re. Half Yearly Report
22nd Nov 20167:00 amRNSHalf-year Report
1st Nov 20164:43 pmRNSTotal Voting Rights
5th Oct 20165:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:31 pmRNSTotal Voting Rights
29th Sep 201610:00 amRNSInvestor Event
27th Sep 20169:37 amRNSDirectorate Change
23rd Sep 20164:27 pmRNSDirectorate Change
1st Sep 20165:25 pmRNSTotal Voting Rights
22nd Aug 20163:54 pmRNSDirector/PDMR Shareholding
10th Aug 20163:26 pmRNSDirector/PDMR Shareholding
1st Aug 20169:00 amRNSTotal Voting Rights
28th Jul 20163:06 pmRNSDirector/PDMR Shareholding
21st Jul 20166:01 pmRNSResult of AGM
21st Jul 20167:00 amRNSAGM Trading Update
1st Jul 201612:58 pmRNSTotal Voting Rights
21st Jun 20162:38 pmRNSAnnual Financial Report
14th Jun 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.